Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05029154 · ClinicalTrials.gov registry record · NA
Exercise Preconditioning in Ovarian Cancer
A NA study, sponsored by University of Virginia.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05029154 is a NA study that was terminated before completion, run by University of Virginia. The registered enrollment target is 8 participants.
The verdict
NCT05029154, a NA study, was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if exercise preconditioning can mitigate the off target effects of chemotherapy treatment on measures of cardiovascular function, peripheral neuropathy, and quality of life.
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL High intensity interval exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-10-21 |
| Est. Completion | 2025-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05029154
The ClinicalTrials.gov registry entry for NCT05029154 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT05029154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05029154 about?
NCT05029154 is a clinical study titled "Exercise Preconditioning in Ovarian Cancer". The purpose of this study is to determine if exercise preconditioning can mitigate the off target effects of chemotherapy treatment on measures of cardiovascular function, peripheral neuropathy, and quality of life.
What is the current status of trial NCT05029154?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2021-10-21. Estimated completion is 2025-06-04.
What interventions are being tested in trial NCT05029154?
The interventions under investigation include: Attention control (BEHAVIORAL), High intensity interval exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05029154?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.